Royal Bank of Canada’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Royal Bank of Canada’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,921	Closed	-$3K	–	7885
2023 Q1	$3K	Sell	1,921 -3,325	-63%	-$5.44K	﹤0.01%	6734
2022 Q4	$8K	Buy	5,246 +4,828	+1,155%	+$6.12K	﹤0.01%	6632
2022 Q3	$1K	Buy	418 +258	+161%	+$769	﹤0.01%	7347
2022 Q2	$0	Sell	160 -1,663	-91%	-$10.2K	﹤0.01%	7943
2022 Q1	$13K	Buy	+1,823	New	+$17.9K	﹤0.01%	6857
2021 Q4	–	Sell	-79	Closed	-$1K	–	8041
2021 Q3	$1K	Buy	+79	New	+$785	﹤0.01%	7540
2021 Q2	–	Sell	-6,124	Closed	-$61K	–	7791
2021 Q1	$61K	Buy	+6,124	New	+$63.3K	﹤0.01%	5774

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Royal Bank of Canada's PRDS Position: Q2 2023 in Review

Royal Bank of Canada sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 1,921 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in PRDS in Q1 2021 and held it in 7 quarters. The position peaked at $61K in Q1 2021. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

Royal Bank of Canada reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Royal Bank of Canada sold 1,921 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $3K.
Royal Bank of Canada first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Royal Bank of Canada's Pardes Biosciences, Inc. Common Stock position peaked at $61K in Q1 2021.
59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.